SCHEDULE 13G Filed 2026-09-23 Event — SEC 0001193125-26-399480 →

PERCEPTIVE ADVISORS LLC → Nurix Therapeutics, Inc. NRIX

Stake: — Shares: — Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

7 transactions

0 buys · 6 sales · 1 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

34 filings by this filer

33 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 9.94

17,657,588 shares short · -1.8% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $60.93M

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-09-02	Ring Christine	officer	Option exercise	5,787	$8.72	$50K
2026-09-02	Ring Christine	officer	Sale	5,387	$25.69	$138K
2026-09-02	Ring Christine	officer	Sale	400	$26.64	$11K
2026-08-04	van Houte Hans	officer	Sale	1,794	$23.89	$43K
2026-08-04	van Houte Hans	officer	Sale	2,967	$24.65	$73K
2026-08-04	Hansen Gwenn	officer	Sale	1,500	$23.87	$36K
2026-08-04	Hansen Gwenn	officer	Sale	2,611	$24.64	$64K

Other Filings by PERCEPTIVE ADVISORS LLC

Filed	Form	Issuer	Stake	Shares
2026-10-01	SCHEDULE 13D/A	Kardigan, Inc.	—	8,254,144	view →
2026-08-27	SCHEDULE 13D/A	Immatics N.V.	—	11,418,016	view →
2026-08-25	SCHEDULE 13D/A	LeonaBio, Inc.	19.99%	1,889,403	view →
2026-08-14	SCHEDULE 13D/A	Nautilus Biotechnology, Inc.	9.10%	11,634,211	view →
2026-08-14	SCHEDULE 13D/A	Solid Biosciences Inc.	11.20%	12,046,579	view →
2026-07-23	SCHEDULE 13G	Freenome, Inc.	—	—	view →
2026-07-20	SCHEDULE 13G	Research Alliance Corporation IV	—	—	view →
2026-06-25	SCHEDULE 13D	Kardigan, Inc. KARD	8.90%	8,254,144	view →
2026-01-26	SCHEDULE	TRINITY BIOTECH PLC TRIB	9.90%	1,463,058,248	view →
2026-01-02	SCHEDULE	MeiraGTx Holdings plc MGTX	12.90%	10,441,562	view →
2025-02-21	SCHEDULE	Solid Biosciences Inc. SLDB	15.60%	11,934,679	view →
2025-02-14	SCHEDULE	TRINITY BIOTECH PLC TRIB	20.90%	85,800,000	view →
2025-01-31	SCHEDULE	Nautilus Biotechnology, Inc. NAUT	10.00%	12,594,211	view →
2023-10-17	SC	Cerevel Therapeutics Holdings, Inc.	—	—	view →
2023-06-06	SC	SOLENO THERAPEUTICS INC SLNO	—	—	view →
2023-05-30	SC	SOLENO THERAPEUTICS INC SLNO	—	—	view →
2023-05-25	SC	SOLENO THERAPEUTICS INC SLNO	—	—	view →
2023-04-25	SC	Cerevel Therapeutics Holdings, Inc.	—	—	view →
2022-12-06	SC	Solid Biosciences Inc. SLDB	—	—	view →
2022-07-01	SC	Athira Pharma, Inc. LONA	—	—	view →

Showing 20 of 33

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →